Help us: Donate
Follow us on:



Tag: Biomarkers

May 05, 2021
There is one common public reaction to my talks that bothers me quite a bit. I am worried that after each of my lectures, people will just start taking lots of supplements without regard for dosage or effectiveness, potentially hurting themselves in the process. This is because one of the most common reactions to me...
urine test
April 08, 2021
A lipid metabolite could serve as a novel biomarker to test the performance of senolytics, according to a new study [1]. Such a biomarker can be detected from blood or urine, allowing for non-invasive testing, and experiments have shown that it plays a functional role in cellular senescence. Slowing down to stay safe Cellular senescence...
February 25, 2021
A new study shows that functional deterioration of the nervous system contributes to late-life mortality and identifies a related bloodborne biomarker for all-cause mortality [1]. Neurofilament light chain (NfL) is a structural protein found in nerve cells. The nervous system has been implicated in aging and longevity, so the fact that NfL can be detected...
Polina Mamoshina at Ending Age-Related Diseases 2020
December 02, 2020
At Ending Age-Related Diseases 2020, Dr. Polina Mamoshina of Insilico Medicine gave a talk on the subject of biomarkers of human aging that are generated through deep learning algorithms. Deep learning, an advancement over older algorithms of artificial intelligence, has allowed for the useful collection of various data, including facial analysis, bone x-rays, blood markers,...
Keith Comito Longevity Dividend
November 06, 2020
At the Eurosymposium on Healthy Aging 2020, president Keith Comito discusses how to take lessons from other fields in generating, storing, and using biomarker data systems in order to provide useful information on aging at both the personal and the population levels. This information is currently not standardized, and this makes it difficult to...
Biomarkers of Aging at Ending Age-Related Diseases 2020
October 23, 2020
In this panel discussion from Ending Age-Related Diseases 2020, Vadim Gladyshev of Harvard Medical School chairs a panel with Steve Horvath of UCLA, Kristen Fortney of BioAge Labs, Stanislav Skakun of Biodata, and Peter Fedichev of GERO to discuss biomarkers and their critical role in developing and evaluating drugs and therapies that treat the root...